Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
The World Health Organization (WHO) declared the Emergency of International Concern (PHEIC) for the latest…
India's upcoming teenage sensation Vaibhav Sooryavanshi has scripted a history in IPL (Indian Premier league)by…
The state of Sikkim will implement the Anand Marriage Act, 1909 from June 1, 2026.…
Respectable Deputy Chief Minister Pravati Parida has inaugurated the Nimapara Patha Utsav 2026 in the…
Respectable Chief Minister of Andhra Pradesh N Chandrababu Naidu has announced the major policy to…
Honorable President Droupadi Murmu has approved the increasing the Supreme Court's judge strength from 34…